Login
Home
Charts
Search
Watchlist
Products

Shelter Pharma Ltd

SHELTER·BSE
₹37.00+8.00%Wed, 23 Sept '26 15:06
Industry:Pharmaceuticals Bulk Drugs
Indices:

Shelter Pharma Ltd

SHELTER
BSE
₹37.00
+8.00%
|Wed, 23 Sept '26 15:06
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹62Cr
Close
Close Price
₹37.00
Industry
Industry
Pharmaceuticals Bulk Drugs
PE
Price To Earnings
5.72
PS
Price To Sales
0.85
Revenue
Revenue
₹73Cr
Rev Gr TTM
Revenue Growth TTM
44.36%
PAT Gr TTM
PAT Growth TTM
24.69%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
1719192124273340
Growth YoY
Revenue Growth YoY%
13.48.324.628.438.449.8
Expenses
ExpensesCr
1415151619212733
Operating Profit
Operating ProfitCr
34445566
OPM
OPM%
19.420.122.220.720.419.418.816.2
Other Income
Other IncomeCr
00000000
Interest Expense
Interest ExpenseCr
00000000
Depreciation
DepreciationCr
00000000
PBT
PBTCr
34445566
Tax
TaxCr
11111122
PAT
PATCr
23334455
Growth YoY
PAT Growth YoY%
29.211.014.218.627.122.4
NPM
NPM%
14.114.716.115.114.713.913.511.4
EPS
EPS₹
0.00.02.72.73.13.23.92.6
QuarterSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
1719192124273340
Growth YoY
Revenue Growth YoY%
13.48.324.628.438.449.8
Expenses
ExpensesCr
1415151619212733
Operating Profit
Operating ProfitCr
34445566
OPM
OPM%
19.420.122.220.720.419.418.816.2
Other Income
Other IncomeCr
00000000
Interest Expense
Interest ExpenseCr
00000000
Depreciation
DepreciationCr
00000000
PBT
PBTCr
34445566
Tax
TaxCr
11111122
PAT
PATCr
23334455
Growth YoY
PAT Growth YoY%
29.211.014.218.627.122.4
NPM
NPM%
14.114.716.115.114.713.913.511.4
EPS
EPS₹
0.00.02.72.73.13.23.92.6

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
30223036405173
Growth
Revenue Growth%
-25.233.720.310.726.644.4
Expenses
ExpensesCr
30222728314160
Operating Profit
Operating ProfitCr
003891013
OPM
OPM%
0.80.89.922.521.419.917.4
Other Income
Other IncomeCr
000-1000
Interest Expense
Interest ExpenseCr
0000000
Depreciation
DepreciationCr
0000000
PBT
PBTCr
003781012
Tax
TaxCr
0012223
PAT
PATCr
0025679
Growth
PAT Growth%
-48.74,897.6152.819.116.724.7
NPM
NPM%
0.30.26.814.415.514.312.3
EPS
EPS₹
1.80.942.56.75.46.36.6
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
30223036405173
Growth
Revenue Growth%
-25.233.720.310.726.644.4
Expenses
ExpensesCr
30222728314160
Operating Profit
Operating ProfitCr
003891013
OPM
OPM%
0.80.89.922.521.419.917.4
Other Income
Other IncomeCr
000-1000
Interest Expense
Interest ExpenseCr
0000000
Depreciation
DepreciationCr
0000000
PBT
PBTCr
003781012
Tax
TaxCr
0012223
PAT
PATCr
0025679
Growth
PAT Growth%
-48.74,897.6152.819.116.724.7
NPM
NPM%
0.30.26.814.415.514.312.3
EPS
EPS₹
1.80.942.56.75.46.36.6

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0008121217
Reserves
ReservesCr
7787243156
Current Liabilities
Current LiabilitiesCr
3346157
Non Current Liabilities
Non Current LiabilitiesCr
0001111
Total Liabilities
Total LiabilitiesCr
11101321384884
Current Assets
Current AssetsCr
881019303355
Non Current Assets
Non Current AssetsCr
323381529
Total Assets
Total AssetsCr
11101321384884
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0008121217
Reserves
ReservesCr
7787243156
Current Liabilities
Current LiabilitiesCr
3346157
Non Current Liabilities
Non Current LiabilitiesCr
0001111
Total Liabilities
Total LiabilitiesCr
11101321384884
Current Assets
Current AssetsCr
881019303355
Non Current Assets
Non Current AssetsCr
323381529
Total Assets
Total AssetsCr
11101321384884

Cash Flow

Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0010-25-12
Investing Cash Flow
Investing Cash FlowCr
00-10-5-7-15
Financing Cash Flow
Financing Cash FlowCr
000011025
Net Cash Flow
Net Cash FlowCr
00005-2-2
Free Cash Flow
Free Cash FlowCr
0000-33-14
CFO To PAT
CFO To PAT%
-337.0-685.425.10.1-31.674.9-138.3
CFO To EBITDA
CFO To EBITDA%
-116.4-162.717.40.0-22.953.9-98.1
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0010-25-12
Investing Cash Flow
Investing Cash FlowCr
00-10-5-7-15
Financing Cash Flow
Financing Cash FlowCr
000011025
Net Cash Flow
Net Cash FlowCr
00005-2-2
Free Cash Flow
Free Cash FlowCr
0000-33-14
CFO To PAT
CFO To PAT%
-337.0-685.425.10.1-31.674.9-138.3
CFO To EBITDA
CFO To EBITDA%
-116.4-162.717.40.0-22.953.9-98.1

Ratios

Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
574262
Price To Earnings
Price To Earnings
9.25.85.7
Price To Sales
Price To Sales
1.40.80.8
Price To Book
Price To Book
1.61.00.9
EV To EBITDA
EV To EBITDA
6.13.94.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
4.34.513.026.426.626.023.423.4
OPM
OPM%
0.80.89.922.521.419.917.417.4
NPM
NPM%
0.30.26.814.415.514.312.312.3
ROCE
ROCE%
1.50.931.542.822.922.416.816.8
ROE
ROE%
1.10.623.435.817.316.912.412.4
ROA
ROA%
0.80.416.024.316.415.010.710.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
574262
Price To Earnings
Price To Earnings
9.25.85.7
Price To Sales
Price To Sales
1.40.80.8
Price To Book
Price To Book
1.61.00.9
EV To EBITDA
EV To EBITDA
6.13.94.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
4.34.513.026.426.626.023.423.4
OPM
OPM%
0.80.89.922.521.419.917.417.4
NPM
NPM%
0.30.26.814.415.514.312.312.3
ROCE
ROCE%
1.50.931.542.822.922.416.816.8
ROE
ROE%
1.10.623.435.817.316.912.412.4
ROA
ROA%
0.80.416.024.316.415.010.710.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Shelter Pharma Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/1r8no2maoic17x8tps5c4q2d.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/l7eiqwbplpxwtu63s7v21myl.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/e4i4x7b8xkc9s728aqhgoxui.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/pbnd6e8kndpgs4uk8cn8kvh2.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/17iezfd5ovjc5j1u4ebm30r0.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/5aisqy71ksc0kwl9ll72dv2b.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/zqgni3m3kty4dhvsyucgtg40.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/r5nrs8e0isat604v36q6gisv.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/aaoaanq41yc23xyan6gnmy58.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/p7zymlm57zfqxypobh8yeur6.pdf

Concall Transcript Summaries — Shelter Pharma Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/BSE%3ASHELTER/transcript-notes/202603/1r8no2maoic17x8tps5c4q2d.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies